Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc (SNDX) Straddle
SNDX straddle scan found 50 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 54.4%.
Read more
Trading a SNDX straddle lets you take a pure volatility position on Syndax Pharmaceuticals Inc without committing to a direction. Syndax Pharmaceuticals Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate SNDX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on SNDX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Syndax Pharmaceuticals Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the SNDX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat.
It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the SNDX straddle is the cleanest expression of that view. Our scanner prices every SNDX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a SNDX straddle into a catalyst or short a SNDX straddle to harvest decay, the options straddle setups that matter are all in one place.
| Jan 21, 2028 | 27.00 | $13.75 | 487 | 23% | 54.4% | $40.75 | $13.25 | 0 |
| Oct 16, 2026 | 21.00 | $3.35 | 25 | 23% | 50.9% | $24.35 | $17.65 | 43 |
| Jan 15, 2027 | 28.00 | $11.00 | 116 | 23% | 50.8% | $39.00 | $17.00 | 0 |
| Apr 16, 2027 | 28.00 | $12.23 | 207 | 23% | 50.6% | $40.23 | $15.78 | 0 |
| Oct 16, 2026 | 25.00 | $7.13 | 25 | 23% | 50.3% | $32.13 | $17.88 | 15 |
| Jan 15, 2027 | 25.00 | $8.45 | 116 | 23% | 50.1% | $33.45 | $16.55 | 109 |
| Jan 21, 2028 | 22.00 | $11.00 | 487 | 23% | 50.0% | $33.00 | $11.00 | 2 |
| Jan 15, 2027 | 26.00 | $9.38 | 116 | 23% | 49.5% | $35.38 | $16.63 | 0 |
| Jan 21, 2028 | 25.00 | $13.45 | 487 | 23% | 48.6% | $38.45 | $11.55 | 116 |
| Apr 16, 2027 | 25.00 | $10.13 | 207 | 23% | 48.5% | $35.13 | $14.88 | 0 |
As of September 22, 2026
Find the right straddle before volatility moves
Track SNDX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→